Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Shanghai Shyndec Pharmaceutical (600420 CH)
Watchlist
15
Analysis
Health Care
•
China
Shanghai Shyndec Pharmaceutical Co.,Ltd. develops, manufactures and distributes pharmaceuticals. The Company's products include antibiotics, hypertension drugs, diet pills, anti-aging drugs, biological products and medicine preparations.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Shanghai Shyndec Pharmaceutical
•
14 Apr 2024 16:11
China Healthcare Weekly (Apr14)- Shanghai Shyndec Pharma,Innovative Drug Policy,Ultra Long-Term Bond
China will issue special treasury bonds for healthcare.New policy boosts hope for innovative drugs.Horizontal competition in Taiji and Shanghai...
Xinyao (Criss) Wang
Follow
381 Views
Share
bullish
•
Chongqing Taiji Industry (Group) A
•
10 Nov 2024 09:27
China Healthcare Weekly (Nov.10)-Biotech Model Validation, CNPGC Need to Fulfill Commitment to Taiji
Out-licensing early-stage pipelines is the worst option. China Biotech at a critical point in verifying business models. CNPGC has other methods to...
Xinyao (Criss) Wang
Follow
311 Views
Share
bullish
•
China National Medicines A
•
14 May 2024 08:55
China National Medicines (600511.CH) - After Restructuring, Performance Growth Is Guaranteed
Horizontal competition issue will be solved within 3 years. The restructuring will increase the business concentration/scale/competitiveness of...
Xinyao (Criss) Wang
Follow
295 Views
Share
bullish
•
China Traditional Chinese Medicine
•
06 May 2024 08:55
China TCM (570.HK) Update - Despite Doubts, This Privatization Seems “Mandatory”
Some investors have concerns that the privatization may fail, but China TCM's privatization seems "mandatory", which will lead to spin-off...
Xinyao (Criss) Wang
Follow
555 Views
Share
bullish
•
China Traditional Chinese Medicine
•
10 Apr 2024 08:55
China TCM (570.HK) - Latest Updates on Privatization and the Potential Merger with Taiji Group
The privatization is highly likely to succeed. It's not wise for investors to bet against privatization.Taiji's high-level personnel changes...
Xinyao (Criss) Wang
Follow
687 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x